Recent News

• 03.27.2026 - 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.27.2026 - Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
• 03.27.2026 - Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
• 03.02.2026 - Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
• 03.02.2026 - Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

Recent Filings

• 03.27.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.27.2026 - 8-K Current report
• 03.27.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 3 Initial statement of beneficial ownership of securities
• 03.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - EX-99.1 EX-99.1
• 03.02.2026 - 8-K Current report
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.30.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership